"10.1371_journal.pbio.0020075","plos biology","2004-03-16T00:00:00Z","Julie L Christensen; Douglas E Wright; Amy J Wagers; Irving L Weissman","Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, California, United States of America","JLC, DEW, and AJW conceived and designed the experiments. JLC, DEW, and AJW performed the experiments. JLC, DEW, and AJW analyzed the data. JLC wrote the paper. ILW assisted in the analysis of the data and reviewed the manuscript.","JLC is currently employed by and has stock options in Cellerant Therapeutics, a company seeking to transplant human HSCs. As a former advisory board member of Amgen, ILW owns significant Amgen stock. He also cofounded and consulted for Systemix; cofounded Cellerant Therapeutics, a spin-off from Systemix Novartis to transplant human HSCs; and is a cofounder and a director of Stem Cells, Inc., which is involved in the isolation and study of human central nervous system stem cells, liver-repopulating cells, and pancreatic islet stem/progenitor cells.","2004","03","Julie L Christensen","JLC",4,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
